WARRANT EXERCISE AND EXCHANGE AGREEMENTWarrant Exercise and Exchange Agreement • November 26th, 2018 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations
This Warrant Exercise and Exchange Agreement (this “Agreement”), dated as of November __, 2018, is by and between DelMar Pharmaceuticals, Inc. (the “Company”), and the undersigned holder (the “Holder”) of warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), issued by the Company, which warrant is exercisable until September 22, 2022 at an exercise price (the “Exercise Price”) of $1.25 per share (the “Warrant”).
